Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Kyntra Bio (KYNB) posted Return on Capital Employed [ROCE] of -72.59% for Q2 2026, up 447.12 percentage points from -519.71% a year earlier but down 20.81 percentage points from the prior quarter.

Analysis

Kyntra Bio (KYNB) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Kyntra Bio's Return on Capital Employed [ROCE] came in at -33.30%, up 47.69 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -5.04 percentage points (FY2020 to FY2025).
  • In prior years, Kyntra Bio's Return on Capital Employed [ROCE] was -80.99% in FY2024 (+26.89 pp), -107.88% in FY2023 (-35.93 pp), -71.95% in FY2022 (-21.75 pp) and -50.19% in FY2021 (-21.93 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -519.71% in Q2 2025 to a high of -32.51% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of +42.01 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 447.12 percentage points; the weakest was Q2 2025, with a drop of 379.24 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -51.79% (Q1 2026), -46.33% (Q4 2025) and -32.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn -72.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.59%
Mar 31, 2026 -51.79%
Dec 31, 2025 -46.33%
Sep 30, 2025 -32.51%
Jun 30, 2025 -519.71%
Mar 31, 2025 -99.72%
Dec 31, 2024 -141.68%
Sep 30, 2024 -270.02%
Jun 30, 2024 -140.47%
Mar 31, 2024 -149.43%
Dec 31, 2023 -143.87%
Sep 30, 2023 -105.54%
Jun 30, 2023 -97.35%
Mar 31, 2023 -98.30%
Dec 31, 2022 -89.62%
Sep 30, 2022 -93.51%
Jun 30, 2022 -47.37%
Mar 31, 2022 -55.72%
Dec 31, 2021 -49.18%
Sep 30, 2021 -34.06%
API Access

Kyntra Bio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KYNB&period=max&api_key=YOUR_API_KEY